5-Hydroxymethylcytosine (5-hmC) loss is a marker of malignancy in biliary neoplasms
CONCLUSIONS: Loss of 5-hmC is not unique to intrahepatic cholangiocarcinoma among biliary carcinomas, but is a useful diagnostic marker differentiating malignancies of the biliary tree from benign mimics.PMID:38345293 | DOI:10.1093/ajcp/aqae001
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Miguel S Gonzalez-Mancera Andrew Siref Kambiz Kosari Nicholas Nissen Srinivas Gaddam Andrew Hendifar Arsen Osipov Kevin Waters Danielle Hutchings Maha Guindi Brent K Larson Source Type: research
More News: Adenocarcinoma | Bile | Bile Duct Cancer | Cancer & Oncology | Carcinoma | Cholangiocarcinoma | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Pathology | Study